Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

15 Sep 20
Cronos Group Recognized by the Toronto Stock Exchange’s TSX30 Program
TORONTO , Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020 , the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020
14 Sep 20
Cronos Group Inc. to Present at the CIBC 19th Annual Eastern Institutional Investor Conference
TORONTO , Sept. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the CIBC 19th Annual Eastern Institutional Investor
09 Sep 20
Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth
30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that its Board of Directors has

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Initial filing by director officer or owner of more than ten percent.

Statement of changes in beneficial ownership of securities

Events

08 May 2020 at 8:30 AM EDT
Cronos Group First Quarter 2020 Earnings Conference Call
30 March 2020 at 5:30 PM EDT
Cronos Group Full Year and Fourth Quarter 2019 Earnings Conference Call
30 January 2020 at 3:15 PM MST
Cronos Group at the 23rd Annual CIBC Western Institutional Investor Conference